Inno Pharma Llp - Company Profile

It is a healthcare limited liability partnership based in Daskroi, Gujarat, India, established in 2013.
2013 Daskroi, Gujarat, India Active
Last Updated:
Access Report
About Inno Pharma Llp

Inno Pharma Llp, a active limited liability partnership, was established on 03 June 2013 in Daskroi, Gujarat, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds LLPIN: AAB-5628. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Dipal Sandip Trivedi (Designated Partner), Mital Ashit Chandaria (Designated Partner), Pragnesh Parshotambhai Donga (Designated Partner). Past directors included Navinchandra Lakhamshi Shah. Its latest date of accounts and solvency statement 31 March 2025. It is based at 3Rd Floor, Office No. 12, Amrapali Axiom-1,, Ambali-Bopal Ring Road, Daskroi, Gujarat, 380058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAB-5628

  • Incorporation Date

    03 June 2013

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 12 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -45.91%
  • Profit Growth **** -33.45%
  • Ebitda **** -121.77%
  • Total Assets -19.38%
Company report

Inno Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Inno Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Inno Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Dipal Sandip Trivedi Designated Partner 03 Jun 2013 Current
Mital Ashit Chandaria Designated Partner 25 Oct 2024 Current
Pragnesh Parshotambhai Donga Designated Partner 01 Aug 2024 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 25 Oct 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Inno Pharma Llp.

Inno Pharma Llp, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.91% decrease. The company also saw a substantial fall in profitability, with a 33.45% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Inno Pharma Llp revenue growth over time
Inno Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -45.91%
*******
*******
*******
*******
Revenue from Operations
*******
 -47.43%
*******
*******
*******
*******
Total Assets
*******
 -19.38%
*******
*******
*******
*******
Profit or Loss
*******
 -33.45%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 -121.77%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Inno Pharma Llp?

Unlock access to Inno Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Inno Pharma Llp?

Unlock and access historical data on people associated with Inno Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Inno Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inno Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Inno Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Inno Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Inno Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Director Appointment

    The activity Mital Ashit Chandaria was appointed as a Designated Partner was appointed as a Designated Partner on 25 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Director Appointment

    Pragnesh Parshotambhai Donga was appointed as a Designated Partner was appointed as a Designated Partner on 01 Aug 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Director Appointment

    Dipal Sandip Trivedi was appointed as a Designated Partner was appointed as a Designated Partner on 03 Jun 2013 & has been associated with this company since 12 years 8 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Inno Pharma Llp was registered on 03 Jun 2013 with Roc Ahmedabad & aged 12 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Inno Pharma Llp?

The LLPIN of Inno Pharma Llp is AAB-5628.

Where is Inno Pharma Llp headquartered?

Inno Pharma Llp is headquartered at 3Rd Floor, Office No. 12, Amrapali Axiom-1,, Ambali-Bopal Ring Road, Daskroi, Gujarat, 380058.

When was Inno Pharma Llp incorporated?

Inno Pharma Llp was incorporated on 03 June 2013.

Who are the current directors of Inno Pharma Llp?

The current directors of Inno Pharma Llp are

What is the primary industry of Inno Pharma Llp?

The primary industry of Inno Pharma Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available